IO Biotech Ownership | Who Owns IO Biotech?
IO Biotech Ownership Summary
IO Biotech is owned by 27.60% institutional investors, 0.36% insiders, and 72.04% retail investors. Vivo capital is the largest institutional shareholder, holding 9.37% of IOBT shares. HBM Healthcare Investments AG Ord is the top mutual fund, with 5.99% of its assets in IO Biotech shares.
IOBT Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | IO Biotech | 27.60% | 0.36% | 72.04% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Biotech Stocks | 307.00% | 11.11% | -218.12% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Vivo capital | 6.17M | 9.37% | $8.58M |
Novo | 3.35M | 5.09% | $4.66M |
Marshall wace, llp | 2.11M | 3.20% | $2.93M |
Morgan stanley | 1.97M | 2.99% | $2.31M |
Pfm health sciences, lp | 1.97M | 2.99% | $2.74M |
Bank of america corp /de/ | 1.65M | 2.51% | $1.93M |
Alyeska investment group | 987.65K | 1.50% | $1.16M |
Pivotal bioventure partners investment advisor | 864.20K | 1.31% | $1.20M |
Landscape capital management | 442.20K | 0.67% | $406.82K |
Soleus capital management | 192.67K | 0.29% | $267.81K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Vivo capital | 6.17M | 0.88% | $8.58M |
Pivotal bioventure partners investment advisor | 864.20K | 0.74% | $1.20M |
Novo | 3.35M | 0.33% | $4.66M |
Pfm health sciences, lp | 1.97M | 0.24% | $2.74M |
Sectoral asset management | 117.69K | 0.11% | $163.59K |
Landscape capital management | 442.20K | 0.04% | $406.82K |
Soleus capital management | 192.67K | 0.02% | $267.81K |
Alyeska investment group | 987.65K | 0.01% | $1.16M |
Bridgeway capital management | 174.00K | 0.00% | $160.08K |
Marshall wace, llp | 2.11M | 0.00% | $2.93M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Landscape capital management | 442.20K | 0.04% | 442.20K |
Royal bank of canada | 60.00K | - | 60.00K |
Citadel advisors | 86.89K | - | 28.27K |
Newedge advisors | 24.22K | 0.00% | 24.22K |
Jane street group | 23.72K | - | 23.72K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Samsara biocapital | - | - | -3.64M |
Armistice capital | - | - | -1.54M |
Logos global management lp | - | - | -493.83K |
Pfm health sciences, lp | 1.97M | 0.24% | -369.03K |
Fmr | - | - | -314.60K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Landscape capital management | 442.20K | 0.04% | 442.20K | $406.82K |
Royal bank of canada | 60.00K | - | 60.00K | $55.00K |
Newedge advisors | 24.22K | 0.00% | 24.22K | $33.66K |
Jane street group | 23.72K | - | 23.72K | $25.85K |
Raymond james financial | 1.00K | - | 1.00K | $1.39K |
Sold Out
Holder | Change |
---|---|
Citigroup | -5.00 |
Advisor group | -230.00 |
Redwood wealth management group | -4.17K |
Hrt financial lp | -12.69K |
Virtu financial | -17.95K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 26 | 23.81% | 18,182,707 | -4.64% | 27 | 3.29% | 11 | 175.00% | 8 | - |
Mar 31, 2025 | 1 | -96.15% | 23,717 | -99.88% | - | 0.00% | 1 | -92.31% | - | -100.00% |
Dec 31, 2024 | 12 | -36.84% | 9,874,693 | -58.14% | 14 | 1.17% | 7 | -12.50% | - | -100.00% |
Sep 30, 2024 | 18 | -10.00% | 23,573,928 | -9.96% | 35 | 2.27% | 7 | 16.67% | 2 | -50.00% |
Jun 30, 2024 | 20 | 11.11% | 26,183,049 | -4.24% | 39 | 1.01% | 6 | 20.00% | 4 | -20.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
HBM Healthcare Investments AG Ord | 3.94M | 5.99% | - |
MEDICAL BioHealth EUR Acc | 679.10K | 1.03% | 7.40K |
Fidelity Select Biotechnology | 314.60K | 0.48% | - |
Protea Sectoral Biotech Opps IF USD Acc | 91.44K | 0.14% | - |
Bridgeway Ultra-Small Company Market | 75.00K | 0.11% | - |
Fidelity Nasdaq Composite Index | 33.31K | 0.05% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
May 30, 2025 | Hunter Heidi | - | Buy | $20.88K |
Dec 23, 2024 | Ahmad Qasim Iftikhar | Chief Medical Officer | Buy | $26.55K |
Dec 23, 2024 | Zocca Mai-Britt | Chief Executive Officer | Buy | $10.12K |
Dec 23, 2024 | Sullivan Amy | Chief Financial Officer | Buy | $8.48K |
Dec 23, 2024 | Smith Devin Whittemore | General Counsel | Buy | $9.72K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | 1 | - |
2024 Q4 | 4 | - |
2024 Q3 | - | 2 |
2024 Q2 | - | 1 |
2024 Q1 | - | 1 |
IOBT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools